Blog - Page 59 of 862

November 11, 2025November 10, 2025

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

Newly published two-year clinical data in Investigative Ophthalmology & Visual Science (IOVS) confirm that the MyoPro® Defocus Lens continues to slow myopia progression in children over extended wear.

The findings, now indexed on PubMed, provide additional scientific support for defocus-based spectacle lens options as part of long-term myopia management strategies. The results come from a randomized, double-blind clinical trial conducted at Wenzhou Medical University in China, following children over a 24-month period. The study compared MyoPro® lenses with standard single-vision lenses, assessing changes in refractive error and axial elongation.

According to the published data, MyoPro® lenses maintained a consistent myopia-control effect throughout the two years of follow-up without adverse adaptation concerns or reductions in visual acuity.

“This new two-year data provides powerful clinical evidence that MyoPro® continues to deliver measurable, lasting benefits for children with myopia,” said Olive Su, General Manager of East Optical. “It further strengthens our commitment to supporting independent eye care professionals with scientifically proven technology that’s shaping the future of vision care.”

A Closer Look at the Findings

The study reports that MyoPro® lenses slowed myopia progression by 67% on average, including an 81.2% reduction in the 10–12 age group. Axial elongation was reduced by 50% compared with single-vision controls. Importantly, the two-year extension results show that this effect did not diminish over time, addressing a common concern regarding the long-term efficacy of optical interventions.

Participants across a range of baseline prescriptions demonstrated similar patterns of slowed progression, suggesting that the lens design may have applicability across different patient profiles. Researchers also noted that visual performance remained stable, with no indication of compromised acuity or symptoms associated with defocus-based optical designs.

About the Journal and Scientific Credibility

Investigative Ophthalmology & Visual Science (IOVS) is one of the most widely recognized journals in the vision science and clinical eye research community. It is the flagship peer-reviewed publication of the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest eye and vision research organization. ARVO represents more than 10,000 researchers across 75 countries, and studies accepted into IOVS undergo rigorous scientific and methodological review.

Publication in IOVS generally signals that a study meets high standards for clinical evidence, study design, statistical analysis, and relevance to current scientific understanding. For eye care professionals evaluating myopia management options, the inclusion of this trial in such a reputable journal adds meaningful weight to its findings.

Links to the Published Research

• PubMed: https://pubmed.ncbi.nlm.nih.gov/41174766/
• IOVS Journal: https://iovs.arvojournals.org/article.aspx?articleid=2807126

Full Press Release

The complete press release from East Optical is available HERE.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

November 10, 2025November 10, 2025

Lacoste Redefines Feminine Precision

Optik Voilàs November-December 2025- Marchon Lacoste L2316_770

A refined expression of feminine style, the Lacoste L2316 model features a lightweight metal frame with a sleek silhouette that highlights the eyes.

The laser-engraved Monogram motif and signature green temple detail reflect the brand’s heritage, while adjustable MEM nose pads ensure all-day comfort and a perfect global fit.

Distributed by Marchon: www.marchon.com

About Marchon:

Working with leading brands to constantly push the envelope through distinct designs, innovative materials and clever constructions, Marchon Eyewear’s goal is to consistently design distinctive eyewear that offers accessible quality, style and value.

Marchon is proud of its diversified portfolio of brands, covering key demand segments in the premium end of the market.

Marchon Eyewear distributes its products through a global network of subsidiaries and distributors, serving over 80,000 accounts in more than 100 countries.

Whether helping people access quality care, supporting eye care providers in managing their practice, or partnering with local organizations to aid our communities, VSP Vision™ is there with a comprehensive portfolio of brands that keep health at the center of everything we do. As the first not-for-profit eye health company, care and compassion have led our growth for nearly 70 years. Today, our focus remains on helping those we serve bring their best vision to life.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

November 7, 2025November 10, 2025

A$AP Rocky Expands Creative Partnership with Ray-Ban, Reimagining the Wayfarer Puffer

Ray-Ban ASAP Rocky Wayfarer Puffer Crystal Collection

Ray-Ban’s ongoing collaboration with A$AP Rocky is stepping into new territory with the release of three elevated interpretations of the Wayfarer Puffer. The launch follows Rocky’s appointment earlier this year as the brand’s first Creative Director, marking another step in Ray-Ban’s effort to merge heritage design with contemporary cultural influence.

Rocky’s latest work turns the long-standing Wayfarer silhouette into a series of bold, sculptural pieces, each defined by oversized curves, wide temples, and a palette that leans toward high-impact colour. The collection introduces crystal and diamond embellishment across select models, along with metal temple detailing featuring the Ray-Ban signature.

Wayfarer Puffer Crystal Edition (0RB4940B)

This version adds a layer of texture with crystal-stud detailing across the inflated Puffer frame. The model maintains the familiar square structure while introducing ultra-wide temples and a more pronounced, dimensional profile. It comes in black, blue, red, white, green, and pink.

Wayfarer Puffer Crystal Pavé Edition (0RB4940BP)

Designed as the most visually striking of the crystal variations, the Pavé edition is covered in crystals from front to temple tips. Gold metal accents and the wide-temple logo finish the look. It is offered in black, blue, and white.

Wayfarer Puffer Diamond Edition (0RB4940KG)

Positioned as the premium collector’s model, the Diamond Edition features 1.65 carats of hand-set natural diamonds and 14k gold finishings. Ray-Ban states that all diamonds are sourced from suppliers meeting high ethical-standards requirements. The model is available in classic black or white, along with vivid options such as red, blue, green, and pink.

The full collection reflects Ray-Ban’s push toward statement eyewear rooted in craft but unmistakably shaped by Rocky’s artistic influence. Availability will vary by market.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

November 6, 2025November 5, 2025

Canadian Ophthalmological Society Urges Early Detection as Diabetes Awareness Month Approaches

As Diabetes Awareness Month nears, the Canadian Ophthalmological Society (COS) is sounding the alarm on a serious knowledge gap among Canadians about diabetes-related vision loss.

A new national survey commissioned by COS found that only one in four Canadians (25%) are familiar with diabetic retinopathy, one of the leading causes of blindness in adults. Despite widespread recognition of eye health importance, three in four Canadians remain unaware that diabetes can cause vision loss.

“Three in four Canadians are unaware that diabetes can cause vision loss, which puts many individuals at risk,” said Dr. Mona Dagher, President of the Canadian Ophthalmological Society. “For those living with diabetes, early detection is critical as it allows eye care professionals to identify retinal changes before significant damage occurs and provide timely treatment or referrals. Protecting your vision starts with awareness and action.”

Awareness Lags Behind Other Eye Diseases

The COS survey highlights a troubling contrast between public familiarity with common eye conditions like cataracts (65%) and glaucoma (53%), versus only 25% awareness of diabetic retinopathy. Familiarity is slightly higher among older adults (27% among those aged 55+) and women (27% versus 23% for men), but remains low overall — particularly concerning as diabetes rates continue to climb across all age groups in Canada.

Innovation and AI Could Help Close the Gap

While 92% of Canadians say it’s important to have access to advanced eye exams and treatments, only 75% believe they actually have that access. The COS points to technology and innovation as key tools to bridge the gap, with over half (52%) of Canadians open to using artificial intelligence in diagnostic support.

“We’re seeing rapid advances in diagnostic imaging and AI-supported screening that can help ophthalmologists detect diabetic eye disease earlier than ever before,” added Dr. Dagher. “But awareness and access are equally important; Canadians need to know when to get checked and where to go.”

A Call to Action During Diabetes Awareness Month

The COS urges all Canadians living with or at risk of diabetes to schedule comprehensive eye exams regularly. Early detection can prevent up to 90% of vision loss caused by diabetic retinopathy, underscoring the critical role of routine eye care in managing overall health.

Source: Canadian Ophthalmological Society

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

November 5, 2025November 12, 2025

Time Change: What Science Just Discovered About Our Internal Clock

A team of Montreal-based scientists has uncovered how the brain’s biological clock forms the neural circuits that keep our bodies aligned with the day-night cycle, a breakthrough published in Cell Reports.

Led by Dr. Michel Cayouette of the Montreal Clinical Research Institute (IRCM) and the Université de Montréal, the researchers identified an unexpected player: Müller glial cells in the retina. Once thought to serve a purely structural role, these cells appear essential to the development of neural pathways that synchronize our internal rhythms with the light-dark cycle.

“These results show that the dialogue between nerve cells and their glial partners is crucial for building the system that regulates our circadian rhythms,” said Dr. Cayouette.

How the Retina Helps Keep Time

The study found that Müller glial cells release specific chemical signals that guide light-sensitive neurons in the retina to connect properly with the brain regions that control circadian rhythms. When these signals are missing, neurons become overly reactive, and the biological clock fails to adjust to changes in light exposure.

With most Canadians recently setting their clocks back, the research is timely. Seasonal time shifts are known to disrupt sleep and biological rhythms, often leading to temporary fatigue and mood changes. Understanding how the retina helps the brain adapt to these changes could pave the way for new treatments for circadian rhythm disorders.

Potential for Future Therapies

Disturbances in the circadian system have been linked to conditions such as insomnia, seasonal depression, metabolic imbalance, and even certain cancers. By revealing how these timing circuits form, the study could help researchers develop therapies to prevent or correct such disruptions.

The project, conducted in collaboration with Drs. Nicolas Cermakian and Arjun Krishnaswamy, highlights the intricate cellular communication between the retina and the brain, and how it keeps our internal clock in sync with the world around us.

Source: Université de Montréal – News

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!